期刊文献+

乳腺癌腋淋巴结微小转移与癌组织Survivin基因表达关系的研究 被引量:3

Relationship of micrometastasis in axillary lymph node and survivin gene in breast tissues
暂未订购
导出
摘要 目的探讨乳腺癌腋淋巴结微小转移与Survivin基因表达的关系。方法采用免疫组织化学SP法对34例淋巴结常规HE染色无癌转移的乳腺癌腋淋巴结572枚进行上皮细胞角蛋白19(CK-19)表达和原发癌组织进行Survivin基因表达的检测。结果淋巴结CK-19病例阳性率为26.47%(9/34),淋巴结数阳性率为4.37%(25/572)。Survivin阳性率为32.35%(11/34)。CK-19阳性病例组中Survivin阳性率为55.56%(5/9),CK-19阴性病例组中Survivin阳性率为24%(6/25),CK-19阳性组与CK-19阴性组的Survivin阳性率无显著差异(P>0.05)。结论乳腺癌腋淋巴结微小转移的发生与癌组织凋亡抑制蛋白的表达无明显相关性。 [Objective] To investigate mierometastasis in axillary lymph nodes and its relationship with Survivin gent expression of the tumor tissue in breast cancer. [Methods] 572 lymph nodes and carcinoma tissues from 34 lymph node-negative cases comtirmed by routine pathology were examined by immunohistochemical staining using CK-19 and Survivin respectively. [Results] Micrometastasis were observed in 9 cases of the 34 patients(26.47%). The positive rate of CK-19 of axiUary node was 4.37%(25/572). The positive rate of Survivin was 32.35%(11/34) in breast cancer tissues. The positive rate of CK-19 was no significantly relation with the expression of Survivin gene (P 〈0.05). [Conclusion] The expression of CK-19 of axiUiaris lymph node was irrelevant to the expression of antiapoptosis gene Survivin in breast cancer fissueo
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2005年第17期2612-2614,共3页 China Journal of Modern Medicine
关键词 乳腺癌 腋淋巴结 微小转移 SURVIVIN基因 breast cancer axiUary lymph node micrometastasis Survivin gene
  • 相关文献

参考文献5

二级参考文献33

  • 1谭郁郴 张乃鑫.外科诊断病理学[M].天津:天津科学技术出版社,2000.77-85.
  • 2[1]Haiman CA, Hankinson SE, Spiegelman D, et al. A tetranucleotide repeat polymorphism in CYP19and breast cancer risk [J].Int J Cancer, 2000, 87(2): 204-10.
  • 3[2]Chetrite GS, Cortes-Prieto, Philippe JC, et al. Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues [J]. J Steroid Biochem Mol Biol, 2000, 72:1-2.
  • 4[3]Gos PE, Jarman M, Wilkinson JR, et al. Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo:identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the rat J Steroid Biochem 1986, 24:619-622.
  • 5[4]Dowseltt M, Goss PE, P owles TJ, et al. Jeffcoate SL, Coombes RC: Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal brest cancer[J]. Res, 1987, 47:1957-1961.
  • 6[5]Dowsett M, Cunningham DC, Stein RC, et al. Coombes RC: Does-related endocrine effects and pharmacokinetics or oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients [J]. Cancer Res, 1989, 49:1306-1312.
  • 7[7]Masamura S, Santner SJ, Heitjan DF, et al. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells [J].J Clin Endocrinol Metab, 1995, 80: 2918-2925.
  • 8[8]Lonning PE. Pharmacology of new aromatase inhibitors Breast, 1996,5:202-208.
  • 9Ishida K, Katsuyama T, Sugiyama A, et al. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas [J ]. Cancer, 1997, 79:1069.
  • 10Ike H, Shimada H, Yamaguchi S, et al. Outcome of total pelvic exenteration for primary rectal cancer [J ] . Diseases of the Colon and Rectum, 2003, 46(4) : 474.

共引文献18

同被引文献5

  • 1LI F.Role of survivin and its splice variants in tumorigenesis[J].Br J Cancer,2005,92(2):212-216.
  • 2RODRIGUEZ JA,SPAN SW,FERREIRA CG,et al.CRMI-midiated nuclear export determines the cytoplamsic localization of the antiapoptotic protein surviving[J].Exp Cell Res,2002,275(1):44-53.
  • 3ADIDA C,BERREBI D,PEUCHMAUR M,et al.Anti-apoptosis gene,survivin,and prognosis of neuroblastoma[J].Lancet,1998,351(9106):882-883.
  • 4TANAKA K,LWAMOTO S,GON G,et al.Expression of survivin and its relationship to loss of apoptosis in breast carcinomas[J].Clin Cancer Res,2000,6(3):12-15.
  • 5MAGA G,HUBSCHER U.Proliferating cell nuclear antigen (PCNA):a dancer with many partners[J].J Cell Sci,2003,116(Pt15):3051-3060.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部